Form 8-K - Current report:
SEC Accession No. 0000353569-22-000008
Filing Date
2022-01-27
Accepted
2022-01-27 16:07:01
Documents
13
Period of Report
2022-01-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K qdel-20220122.htm   iXBRL 8-K 32348
  Complete submission text file 0000353569-22-000008.txt   196218

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT qdel-20220122.xsd EX-101.SCH 2247
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT qdel-20220122_def.xml EX-101.DEF 14507
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT qdel-20220122_lab.xml EX-101.LAB 28042
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT qdel-20220122_pre.xml EX-101.PRE 15006
7 EXTRACTED XBRL INSTANCE DOCUMENT qdel-20220122_htm.xml XML 10745
Mailing Address 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121
Business Address 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121 8585521100
QUIDEL CORP /DE/ (Filer) CIK: 0000353569 (see all company filings)

EIN.: 942573850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-10961 | Film No.: 22563214
SIC: 2835 In Vitro & In Vivo Diagnostic Substances